Orchestra BioMed Holdings (OBIO) Revenue (2022 - 2026)
Orchestra BioMed Holdings (OBIO) reported Revenue of $110000.0 for Q1 2026, down 87.33% year-over-year from $868000.0 in Q1 2025, and down 99.64% on a QoQ basis from $30.9 million in Q4 2025.
Orchestra BioMed Holdings (OBIO) has 5 years of Revenue data on file, last reported at $110000.0 in Q1 2026.
- Quarterly Revenue fell 87.33% year-over-year to $110000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.7 million (up 1033.89% YoY) and the FY2025 annual result came in at $33.5 million, up 1169.22% from the prior year.
- Revenue slipped to $110000.0 in Q1 2026 per OBIO's latest filing, from $30.9 million in the prior quarter.
- Across five years, Revenue topped out at $30.9 million in Q4 2025 and bottomed at $110000.0 in Q1 2026.
- The 5-year median for Revenue is $861000.0 (2025), against an average of $2.5 million.
- The widest annual swing landed in 2025, when Revenue surged 12120.16%; it then tumbled 87.33% in 2026.
- Tracing OBIO's Revenue over 5 years: stood at $1.1 million in 2022, then slumped by 76.25% to $262000.0 in 2023, then fell by 3.44% to $253000.0 in 2024, then surged by 12120.16% to $30.9 million in 2025, then plunged by 99.64% to $110000.0 in 2026.
- Per Business Quant, the three latest OBIO Revenue figures stand at $110000.0 (Q1 2026), $30.9 million (Q4 2025), and $861000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Orchestra BioMed Holdings | 245.24 Mn | 255.02 Mn | 78,000.00 | 110,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 110,000.00 |
| Dec 31, 2025 | 30.92 Mn |
| Sep 30, 2025 | 861,000.00 |
| Jun 30, 2025 | 836,000.00 |
| Mar 31, 2025 | 868,000.00 |
| Dec 31, 2024 | 253,000.00 |
| Sep 30, 2024 | 987,000.00 |
| Jun 30, 2024 | 778,000.00 |
| Mar 31, 2024 | 620,000.00 |
| Dec 31, 2023 | 262,000.00 |
| Sep 30, 2023 | 419,000.00 |
| Jun 30, 2023 | 915,000.00 |
| Mar 31, 2023 | 1.16 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | 1.16 Mn |
| Jun 30, 2022 | 401,000.00 |
| Mar 31, 2022 | 866,000.00 |